GT BIOPHARMA, INC. Operating Expenses
GT BIOPHARMA, INC. (GTBP) reported Operating Expenses of $1.99 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-15
- GT BIOPHARMA, INC. operating expenses for the quarter ending 2026-03-31 was $1.99M, a 307.17% increase year-over-year.
- GT BIOPHARMA, INC. operating expenses for the quarter ending 2025-03-31 was $488.00K.
- GT BIOPHARMA, INC. operating expenses for the quarter ending 2020-09-30 was $1.95M, a 78.04% decline year-over-year.
- GT BIOPHARMA, INC. operating expenses for the quarter ending 2020-06-30 was $1.56M, a 31.64% decline year-over-year.
- GT BIOPHARMA, INC. operating expenses for fiscal 2023 was $13.58M, a 36.13% decline from fiscal 2022.
- GT BIOPHARMA, INC. operating expenses for fiscal 2022 was $21.26M, a 63.04% decline from fiscal 2021.
- GT BIOPHARMA, INC. operating expenses for fiscal 2021 was $57.52M.
- GT BIOPHARMA, INC. operating expenses for fiscal 2019 was $16.06M, a 93.58% decline from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $1.99M 10-Q · filed 2026-05-15 | ||||
| 2025-03-31 | $488.00K 10-Q · filed 2026-05-15 | ||||
| 2023-12-31 | $13.58M 10-K · filed 2024-03-26 | ||||
| 2022-12-31 | $21.26M 10-K · filed 2024-03-26 | ||||
| 2021-12-31 | $57.52M 10-K · filed 2023-03-30 | ||||
| 2020-09-30 | $1.95M 10-Q · filed 2020-11-13 | $3.50M derived: sum of 2 quarters · filed 2020-11-13 | $4.57M 10-Q · filed 2020-11-13 | $5.44M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2020-06-30 | $1.56M 10-Q/A · filed 2020-08-18 | $2.63M 10-Q/A · filed 2020-08-18 | $3.49M derived: sum of 3 quarters · filed 2020-08-18 | $12.35M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2020-03-31 | $1.07M 10-Q · filed 2020-05-15 | $1.94M derived: sum of 2 quarters · filed 2020-05-15 | $10.79M derived: sum of 3 quarters · filed 2020-11-13 | $13.07M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $9.72M derived: sum of 2 quarters · filed 2020-11-13 | $12.00M derived: sum of 3 quarters · filed 2020-11-13 | $16.06M 10-K · filed 2020-03-27 | |
| 2019-09-30 | $8.86M 10-Q · filed 2020-11-13 | $11.13M derived: sum of 2 quarters · filed 2020-11-13 | $15.19M 10-Q · filed 2020-11-13 | $18.28M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $2.28M 10-Q/A · filed 2020-08-18 | $6.33M 10-Q/A · filed 2020-08-18 | $9.43M derived: sum of 3 quarters · filed 2020-08-18 | $244.09M derived: sum of 4 quarters · filed 2020-08-18 | |
| 2019-03-31 | $4.06M 10-Q · filed 2020-05-15 | $7.15M derived: sum of 2 quarters · filed 2020-05-15 | $241.81M derived: sum of 3 quarters · filed 2020-05-15 | $246.97M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $237.75M derived: sum of 2 quarters · filed 2020-03-27 | $242.91M derived: sum of 3 quarters · filed 2020-03-27 | $250.07M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $234.66M 10-Q · filed 2019-11-14 | $239.82M derived: sum of 2 quarters · filed 2019-11-14 | $246.98M 10-Q · filed 2019-11-14 | $252.87M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $5.16M 10-Q · filed 2019-08-14 | $12.32M 10-Q · filed 2019-08-14 | $18.21M derived: sum of 3 quarters · filed 2019-08-14 | $145.06M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $7.16M 10-Q · filed 2019-05-15 | $13.05M derived: sum of 2 quarters · filed 2019-05-15 | $139.91M derived: sum of 3 quarters · filed 2019-05-15 | $141.19M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $132.75M derived: sum of 2 quarters · filed 2019-03-29 | $134.03M derived: sum of 3 quarters · filed 2019-03-29 | $135.57M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $126.86M 10-Q · filed 2018-11-14 | $128.14M derived: sum of 2 quarters · filed 2018-11-14 | $129.68M 10-Q · filed 2018-11-14 | $130.50M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $1.28M 10-Q · filed 2018-08-14 | $2.82M 10-Q · filed 2018-08-14 | $3.65M derived: sum of 3 quarters · filed 2018-08-14 | $6.17M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $1.54M 10-Q · filed 2018-05-15 | $2.36M derived: sum of 2 quarters · filed 2018-05-15 | $4.89M derived: sum of 3 quarters · filed 2018-05-15 | $7.01M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $822.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $3.35M derived: sum of 2 quarters · filed 2018-03-01 | $5.47M derived: sum of 3 quarters · filed 2018-03-01 | $9.37M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $2.53M 10-Q/A · filed 2018-02-28 | $4.65M derived: sum of 2 quarters · filed 2018-02-28 | $8.55M 10-Q/A · filed 2018-02-28 | $11.46M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $2.12M 10-Q/A · filed 2018-02-28 | $6.02M 10-Q/A · filed 2018-02-28 | $8.93M derived: sum of 3 quarters · filed 2018-02-28 | $11.71M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $3.90M 10-Q/A · filed 2018-02-28 | $6.81M derived: sum of 2 quarters · filed 2018-02-28 | $9.59M derived: sum of 3 quarters · filed 2018-02-28 | $11.04M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $2.91M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $5.68M derived: sum of 2 quarters · filed 2018-02-28 | $7.14M derived: sum of 3 quarters · filed 2018-02-28 | $8.95M 10-K/A · filed 2018-02-28 | |
| 2015-09-30 | $2.78M 10-Q/A · filed 2018-02-28 | $4.23M derived: sum of 2 quarters · filed 2018-02-28 | $6.05M 10-Q/A · filed 2018-02-28 | $7.69M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-06-30 | $1.45M 10-Q/A · filed 2018-02-28 | $3.27M 10-Q/A · filed 2018-02-28 | $4.91M derived: sum of 3 quarters · filed 2018-02-28 | $5.46M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-03-31 | $1.82M 10-Q/A · filed 2018-02-28 | $3.46M derived: sum of 2 quarters · filed 2018-02-28 | $4.00M derived: sum of 3 quarters · filed 2018-02-28 | $4.12M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2014-12-31 | $1.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $2.19M derived: sum of 2 quarters · filed 2018-02-28 | $2.30M derived: sum of 3 quarters · filed 2018-02-28 | $2.40M 10-K/A · filed 2018-02-28 | |
| 2014-09-30 | $547.00K 10-Q · filed 2015-11-13 | $659.00K derived: sum of 2 quarters · filed 2015-11-13 | $760.00K 10-Q · filed 2015-11-13 | $1.01M derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $112.00K 10-Q · filed 2015-08-14 | $213.00K 10-Q · filed 2015-08-14 | $464.00K derived: sum of 3 quarters · filed 2015-08-14 | $665.00K derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $101.00K 10-Q · filed 2015-05-14 | $352.00K derived: sum of 2 quarters · filed 2015-05-14 | $553.00K derived: sum of 3 quarters · filed 2015-05-14 | $671.00K derived: sum of 4 quarters · filed 2015-05-14 | |
| 2013-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $452.00K derived: sum of 2 quarters · filed 2015-03-31 | $570.00K derived: sum of 3 quarters · filed 2015-03-31 | $935.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $201.00K 10-Q · filed 2014-12-17 | $319.00K derived: sum of 2 quarters · filed 2015-01-08 | $684.00K 10-Q · filed 2015-01-08 | $1.58M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2013-06-30 | $118.00K 10-Q · filed 2015-01-08 | $484.00K 10-Q · filed 2015-01-08 | $1.38M derived: sum of 3 quarters · filed 2015-01-08 | $2.82M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2013-03-31 | $366.00K 10-Q · filed 2015-01-08 | $1.26M derived: sum of 2 quarters · filed 2015-01-08 | $2.70M derived: sum of 3 quarters · filed 2015-01-08 | $3.73M derived: sum of 4 quarters · filed 2015-01-08 | |
| 2012-12-31 | $897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $2.33M derived: sum of 2 quarters · filed 2015-01-08 | $3.37M derived: sum of 3 quarters · filed 2015-01-08 | $3.76M 10-K · filed 2015-01-08 | |
| 2012-09-30 | $1.44M 10-Q · filed 2014-12-17 | $2.47M derived: sum of 2 quarters · filed 2014-12-17 | $2.87M 10-Q · filed 2014-12-17 | $3.92M derived: sum of 4 quarters · filed 2014-12-17 | |
| 2012-06-30 | $1.03M 10-Q · filed 2014-12-12 | $1.43M 10-Q · filed 2014-12-12 | $2.48M derived: sum of 3 quarters · filed 2014-12-12 | $3.01M derived: sum of 4 quarters · filed 2014-12-12 | |
| 2012-03-31 | $397.00K 10-Q · filed 2014-12-10 | $396.00K 10-Q · filed 2012-05-21 | $1.45M derived: sum of 2 quarters · filed 2014-12-10 | $1.98M derived: sum of 3 quarters · filed 2014-12-10 | $2.45M derived: sum of 4 quarters · filed 2014-12-10 |
| 2011-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $1.59M derived: sum of 2 quarters · filed 2014-11-18 | $2.05M derived: sum of 3 quarters · filed 2014-11-18 | $3.91M 10-K · filed 2014-11-18 | |
| 2011-09-30 | $535.00K 10-Q · filed 2012-11-21 | $1.00M derived: sum of 2 quarters · filed 2012-11-21 | $2.85M 10-Q · filed 2012-11-21 | $3.33M derived: sum of 4 quarters · filed 2012-11-21 | |
| 2011-06-30 | $467.00K 10-Q/A · filed 2012-09-13 | $2.32M 10-Q/A · filed 2012-09-13 | $2.79M derived: sum of 3 quarters · filed 2012-09-13 | $3.45M derived: sum of 4 quarters · filed 2012-09-13 | |
| 2011-03-31 | $1.85M 10-Q · filed 2012-05-21 | $2.33M derived: sum of 2 quarters · filed 2012-05-21 | $2.98M derived: sum of 3 quarters · filed 2012-05-21 | $3.37M derived: sum of 4 quarters · filed 2012-05-21 | |
| 2010-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $1.13M derived: sum of 2 quarters · filed 2012-04-16 | $1.51M derived: sum of 3 quarters · filed 2012-04-16 | $2.44M 10-K · filed 2012-04-16 | |
| 2010-09-30 | $654.00K 10-Q · filed 2011-11-21 | $1.04M derived: sum of 2 quarters · filed 2011-11-21 | $1.97M 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $386.00K 10-Q/A · filed 2011-09-12 | $1.32M 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |